Thus, either HMGB-1 blockage or TLR antagonist molecules would be able to reduce neuroinflammation and may be a novel target for developing anti-seizure drugs especially for drug-resistant epilepsies or anti-epileptogenic drugs. The gene discussed is HMGB1; the disease is epilepsy.